Genesis Healthcare Inc. (NYSE:GEN) was downgraded by RBC Capital Markets from an “outperform” rating to a “sector perform” rating in a research note issued to investors on Monday. They currently have a $3.50 price target on the stock, up from their prior price target of $3.00. RBC Capital Markets’ target price suggests a potential upside of 4.17% from the stock’s current price.

GEN has been the topic of several other research reports. Royal Bank Of Canada lowered shares of Genesis Healthcare from an “outperform” rating to a “sector perform” rating and boosted their price objective for the stock from $3.00 to $3.50 in a research note on Monday. Bank of America Corp. set a $1.80 price objective on shares of Genesis Healthcare and gave the stock a “sell” rating in a research note on Monday, September 19th. One investment analyst has rated the stock with a sell rating and five have issued a hold rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $2.89.

Analyst Recommendations for Genesis Healthcare (NYSE:GEN)

Genesis Healthcare (NYSE:GEN) opened at 3.36 on Monday. The stock’s 50 day moving average is $2.84 and its 200-day moving average is $2.30. The company’s market capitalization is $304.02 million. Genesis Healthcare has a 52-week low of $1.38 and a 52-week high of $5.14.

Genesis Healthcare (NYSE:GEN) last announced its earnings results on Thursday, November 3rd. The company reported ($0.23) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.17. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.39 billion. The company’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.07 EPS. Analysts predict that Genesis Healthcare will post ($1.20) EPS for the current fiscal year.

Large investors have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Genesis Healthcare by 2,375.2% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 37,796 shares of the company’s stock valued at $101,000 after buying an additional 36,269 shares during the last quarter. Alliancebernstein L.P. raised its stake in Genesis Healthcare by 5.8% in the second quarter. Alliancebernstein L.P. now owns 77,126 shares of the company’s stock valued at $137,000 after buying an additional 4,200 shares during the last quarter. LPL Financial LLC acquired a new stake in Genesis Healthcare during the third quarter valued at approximately $139,000. Rhumbline Advisers raised its stake in Genesis Healthcare by 84.5% in the third quarter. Rhumbline Advisers now owns 58,531 shares of the company’s stock valued at $156,000 after buying an additional 26,800 shares during the last quarter. Finally, California State Teachers Retirement System raised its stake in Genesis Healthcare by 3.3% in the third quarter. California State Teachers Retirement System now owns 78,158 shares of the company’s stock valued at $209,000 after buying an additional 2,500 shares during the last quarter. 8.73% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Genesis Healthcare Inc. (GEN) Stock Rating Lowered by RBC Capital Markets” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was copied illegally and republished in violation of international copyright law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2016/11/23/genesis-healthcare-inc-gen-stock-rating-lowered-by-rbc-capital-markets.html.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, formerly Skilled Healthcare Group, Inc, is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services, including physician services and other healthcare related services.

5 Day Chart for NYSE:GEN

Receive News & Stock Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related stocks with our FREE daily email newsletter.